Navigation Links
Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
Date:7/23/2009

of $60,000 related to the previously divested SYNVISC(R) product line. Further, Other (income) expense, net included pre-tax gains from product divestitures of $4,196 and $29,351 for the 2009 second quarter and first half, respectively, compared with $10,143 and $33,201 for the 2008 second quarter and first half, respectively.
  • Certain significant items related to our productivity initiatives and the proposed merger with Pfizer have been excluded from the results of operations - as adjusted for the 2009 and 2008 second quarter and first half as follows:
  • Productivity Initiatives

                                                        (UNAUDITED)
                                        -----------------------------------------
                                         Three Months Ended   Six Months Ended
                                        -------------------   -------------------
            (In thousands except per
             Share amounts)             6/30/2009 6/30/2008   6/30/2009 6/30/2008
            --------------------------  --------- ---------   --------- ---------
    
            Cost of Goods Sold            $37,603   $47,641   $104,171  $113,569
            Selling, General and
             Administrative Expenses        6,026   101,551     11,190   202,125
            Research and Development
             Expenses                       1,236     6,008      1,254    25,121
                                            -----     -----      -----    ------
            Total Productivity Initiatives
             Charges(a)                    44,865   155,200    116,615   340,815
            Other Income, Net(b)                -         -          -  (104,655)
                                          -------  --------   --------  --------
            Net Productivity Initiatives
             Charges                      $44,865  $155,200   $116,615  $236,160
                                          =======  ========   ========  ==
    '/>"/>
    SOURCE Wyeth
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine news :

    1. Wyeth Announces Results of the Companys Offer Relating to Holder Right to Surrender Convertible Debentures
    2. Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated For Women and Men
    3. Wyeths Prevenar 13* Receives First Approval
    4. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
    5. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
    6. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
    7. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
    8. DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza
    9. Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
    10. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
    11. Wyeth Reports Earnings Results for the 2009 First Quarter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/30/2015)... May 30, 2015 Venus Viva has ... scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, ... professional, such as Dr. F. Victor Rueckl of Lakes ... clinical trials in Las Vegas. This body image solution ... a system that delivers proven results through a skin ...
    (Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
    (Date:5/29/2015)... MO (PRWEB) May 29, 2015 Based in ... autism awareness shirts for a couple of months ... Their latest release, which reads “I’m not misbehaving, I ... worn by the parent’s of an autistic child in order ... of autism. , Not only are they raising awareness through ...
    (Date:5/29/2015)... 2015 What does community do? , ... community comes together to plant gardens, to teach young ... awareness of critical issues. Community invites everyone to help ... , "What Community Does" was commissioned by The Denver ... and released during the foundation’s Annual Celebration in May. ...
    (Date:5/29/2015)... M3 USA MDLinx.com, source of the ... specialties, now offers The Smartest Rheumatologist . The ... disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis and ... MDLinx, and Caroline Tredway, editorial head of The Smartest ... have on the physicians who participate. Says Tredway, “With ...
    Breaking Medicine News(10 mins):Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2
    ... testing a candidate 2009 H1N1 influenza vaccine in pregnant ... Allergy and Infectious Diseases (NIAID), part of the National ... higher risk of developing severe illness if they become ... they are strongly encouraged to receive the seasonal influenza ...
    ... , , , ... Islands announced that the National Science Foundation (NSF) recently honored ... NSF Faculty Early Career Development (CAREER) award. , ... recognition of Gillespie,s teaching and research in protein-ligand interactions and ...
    ... to staph infections, researchers say , WEDNESDAY, Sept. 9 ... properties, might kill MRSA bacteria. , A new study ... honey, made solely from flowers found on the New ... protein, which is needed for fatty acid biosynthesis. The ...
    ... Tysabri appears to awaken dormant, common virus that crosses over ... may have discovered part of the reason why Tysabri, a ... development of a rare but potentially deadly brain disease in ... dormant JC virus from its slumber, allowing it to cross ...
    ... WASHINGTON, Sept. 9 Statement of Lisa A. Rickard, ... reports from White House press secretary Robert Gibbs that President ... Congress: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO ... encouraged that President Obama understands the tremendous burden that medical ...
    ... , , HOFFMAN ESTATES, Ill., Sept. ... open tomorrow, Thursday, Sept. 10, and will continue through October 30, ... 900 Kmart Pharmacy locations for $25 while supplies last. ... your home for family health," says Robbert Ayshford, RPh, divisional vice ...
    Cached Medicine News:Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 3
    (Date:5/29/2015)... MENLO PARK, Calif. , May ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, presented ... of Cancer Research (AACR) Advances in Brain Cancer ... lead product candidate VAL-083 (dianhydrogalactitol) to ...
    (Date:5/29/2015)...  Eli Lilly and Company (NYSE: LLY ) ... they have entered into a clinical trial collaboration to ... anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ... medicine. The planned study will assess the combination as ... The Phase I study is expected to establish ...
    (Date:5/29/2015)...  World-renowned prostate surgeon and New York Urologist, Dr. ... MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive prostate ... at Lenox Hill Hospital is the only center using ... New York City . We,ve seen tremendous improvement in ... use of an MRI makes for a much more accurate ...
    Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
    ... Nov. 14 The American Legion,welcomes the findings of ... scheduled to be released on Nov 14., "In ... on the health,of military personnel who have served in ... stress is timely and important," said Marty,Conatser, national commander ...
    ... Group, Inc.,(OTC Bulletin Board: ANPG), reported today ... the selection of its,disinfectant, EnviroTru(TM) for use ... EnviroTru(TM) is a multi-purpose disinfectant and ... meets EPA requirements for,Toxicity Category IV (no ...
    Cached Medicine Technology:American Legion Anticipates Institute of Medicine Report on Gulf War Veterans 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3
    ... next generation of the ultra-quiet ... III retains all the smooth, ... a leading name for,aspiration surgery ... pumps for high powered operation, ...
    Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
    ... term being used today to describe the nature of ... may have been used in silicone implants in the ... not new technology cohesive is simply a word ... nature of the gel. All of Mentor silicone gel-filled ...
    A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
    Medicine Products: